inyección glp-1 precio Medicare cubrirá medicamento para adelgazar por $50 al mes: ¿Quiénes califican? La FDA aprueba una mayor

The study of 333,687 veterans compared 132,551 participants who were prescribed GLP-1s for their type 2 diabetes with 201,136 participants who were prescribed sulfonylureas, another treatment for diabetes, and followed the patients outcomes for up to three years

GLP-1 therapies have demonstrated substantial weight-reduction benefits, with studies showing an average weight loss of 4.6 kg, a BMI reduction of 2.1 kg/m, and a decrease in waist circumference of 4.6 cm compared to placebo

doi: 10.1152/ajpendo.00317.2009 148 LiesaMShirihaiOS

"Update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity"

Tirzepatide (Mounjaro/Zepbound) follows a similar principle